Vinge has advised Atria in conjunction with the sale of its holding in Nordic Fast Food AB to the previous minority shareholder Svenska Franchisetagarnas Intresse AB (FIAB).
The board of directors of Hansa Medical has resolved on a directed new issue of ordinary shares, subject to approval by an extraordinary general meeting, whereby Hansa Medical will raise proceeds of approximately SEK 545 million, before issue costs.
Vinge advises Infant Bacterial Therapeutics AB (publ) (Nasdaq First North Premier) in connection with a combined directed issue and rights offering of approximately SEK 545 million.
Vinge together with the Italian law firm Pavia e Ansaldo have advised WallVision in conjunction with the acquisition of the Italian premium brand Wall&decó.
Vinge acts as counsel to Orkla in connection with the acquisition of Health and Sports Nutrition Group HSNG AB (”HSNG”). The seller is Qliro Group AB (publ).
Swedish Oat Fiber has a leading international market position as a producer of oat beta glucan, dietary fiber, oat oils and oat proteins for use in the food, health, cosmetics and animal food industries. The company’s head office and manufacturing facility is situated in Bua outside Gothenburg.
Vinge has advised funds managed by Triton in connection with the acquisition of KEWAB, a supplementary acquisition to Akeab. KEWAB is a leading supplier of excavation services, facility and power supply work in western Sweden.
